Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)

Update Il y a 4 ans
Reference: NCT01600573

Woman Man

  • | Country :
  • Germany
  • | organs :
  • -
  • | Specialty :
  • -

Extract

This clinical trial shall clarify the efficacy and safety of pazopanib in combination with weekly topotecan in patients with platinum-resistant or intermediate platinum-sensitive recurrent epithelial ovarian cancer, fallopian and peritoneal carcinoma


Inclusion criteria

  • Ovarian Cancer

Links